![]() |
UOB achieved tight pricing and an upsized transaction due to robust market demand that is well-balanced across the three tranches. The Bank also achieved the tightest spread for 3-year FXD and FRN amongst APAC ex-Japan and ex-China USD FIG senior notes since early 2022.
Ms Koh Chin Chin, Head of Group Treasury, Research and Customer Advocacy, UOB, said, "The USD market continues to be one of our deepest liquidity sources. After a brief hiatus, we set out to re-engage the widest global investor community and establish new benchmarks across different formats and tenors. Notwithstanding the growing headwinds, it has been very heartening to see such a solid reception from our real money investors, allowing us to surpass our size expectations at very competitive funding levels."
Salient points about this offering
- Nimble in navigation around recent volatility and geopolitical situation; intraday execution to minimise overnight risks
- Offered FXD and FRN tranches catering to both yield and spread buyers; offered 3-year and 5-year tenors catering to a larger group of target investors with different tenor preferences/requirements
- Zero new issue concession in both 3-year FXD and 3-year FRN tranches, negative 5 bp new issue concession in 5-year FRN tranche
- Strong momentum from Asian investors, allowing the Bank to tighten pricing by 25 bp for all tranches from initial pricing guidance to final pricing
- Global distribution targeting all pools of USD liquidity globally, including 59% to US investors for the 3-year FRN and 40% to US investors for the 3-year FXD
- 3-year FXD tranche
- Final orderbook >US$1.7bn, with Asia ~54%, US ~40% and EMEA ~6%
- Robust investor demand from Banks/Financial Institutions ~43%, Fund Managers ~24%, Central Banks/Official Institutions/Insurance ~24%, Corporates ~ 6%, Others ~3%
- 3-year FRN tranche
- Final orderbook >US$1.3bn, with Asia ~35%, US ~59% and EMEA ~6%
- Robust investor demand from Banks/Financial Institutions ~37%, Fund Managers ~42%, Central Banks/Official Institutions/Insurance ~19%, Others ~2%
- 5-year FRN tranche
- Final orderbook > US$570m, with Asia ~93%, US ~2% and EMEA ~5%
- Robust investor demand from Banks/Financial Institutions ~61%, Fund Managers ~11%, Central Banks/Official Institutions/Insurance ~27%, Others ~1%